SE7909439L - Spiro-polycykliska imidazolidindionderivat - Google Patents

Spiro-polycykliska imidazolidindionderivat

Info

Publication number: SE7909439L
Authority: SE; Sweden
Prior art keywords: spiro; dihydro; derivatives; imidazolidine; dione
Prior art date: 1978-11-16

Application number

SE7909439A

Other languages

English (en)

Other versions

SE447731B (sv

Inventor

R Sarges

J Belletire

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-11-16

Filing date

1979-11-15

Publication date

1980-05-17

1979-11-15 Application filed by Pfizer filed Critical Pfizer

1980-05-17 Publication of SE7909439L publication Critical patent/SE7909439L/sv

1986-12-08 Publication of SE447731B publication Critical patent/SE447731B/sv

Links

-1 IMIDAZOLIDE INDION DERIVATIVES Chemical class 0.000 title 1
UXNCDAQNSQBHEN-UHFFFAOYSA-N 1,2,3,4-tetrahydrophenanthrene Chemical class C1=CC2=CC=CC=C2C2=C1CCCC2 UXNCDAQNSQBHEN-UHFFFAOYSA-N 0.000 abstract 2
DXBHBZVCASKNBY-UHFFFAOYSA-N 1,2-Benz(a)anthracene Chemical class C1=CC=C2C3=CC4=CC=CC=C4C=C3C=CC2=C1 DXBHBZVCASKNBY-UHFFFAOYSA-N 0.000 abstract 1
QMDFJHAAWUGVKQ-UHFFFAOYSA-N 2h-thiopyran Chemical compound C1SC=CC=C1 QMDFJHAAWUGVKQ-UHFFFAOYSA-N 0.000 abstract 1
208000002249 Diabetes Complications Diseases 0.000 abstract 1
206010012655 Diabetic complications Diseases 0.000 abstract 1
239000003288 aldose reductase inhibitor Substances 0.000 abstract 1
229940090865 aldose reductase inhibitors used in diabetes Drugs 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
FYBYHGFHUHHCMZ-UHFFFAOYSA-N spiro[1,2-dihydrophenalene-3,5'-imidazolidine]-2',4'-dione Chemical compound N1C(=O)NC(=O)C1(CC1)C2=C3C1=CC=CC3=CC=C2 FYBYHGFHUHHCMZ-UHFFFAOYSA-N 0.000 abstract 1
HSWRZEKKWFQMNN-UHFFFAOYSA-N spiro[3,4-dihydro-2h-benzo[a]anthracene-1,5'-imidazolidine]-2',4'-dione Chemical compound N1C(=O)NC(=O)C11C2=C3C=C4C=CC=CC4=CC3=CC=C2CCC1 HSWRZEKKWFQMNN-UHFFFAOYSA-N 0.000 abstract 1
PEQKPOGYGGKRQS-UHFFFAOYSA-N spiro[3,4-dihydro-2h-phenanthrene-1,5'-imidazolidine]-2',4'-dione Chemical compound N1C(=O)NC(=O)C11C(C=CC=2C3=CC=CC=2)=C3CCC1 PEQKPOGYGGKRQS-UHFFFAOYSA-N 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Ophthalmology & Optometry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

SE7909439A 1978-11-16 1979-11-15 Spiro-polycykliska imidazolidindionderivat SE447731B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US05/961,335 US4181728A (en)	1978-11-16	1978-11-16	Spiro-polycyclicimidazolidinedione derivatives

Publications (2)

Publication Number	Publication Date
SE7909439L true SE7909439L (sv)	1980-05-17
SE447731B SE447731B (sv)	1986-12-08

Family

ID=25504341

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7909439A SE447731B (sv)	1978-11-16	1979-11-15	Spiro-polycykliska imidazolidindionderivat

Country Status (23)

Country	Link
US (1)	US4181728A (sv)
JP (2)	JPS6052157B2 (sv)
AR (1)	AR222052A1 (sv)
AT (1)	AT369742B (sv)
AU (1)	AU515301B2 (sv)
BE (1)	BE880065A (sv)
CA (1)	CA1125294A (sv)
CH (1)	CH642358A5 (sv)
DE (1)	DE2946037A1 (sv)
DK (1)	DK484479A (sv)
ES (1)	ES486007A1 (sv)
FI (1)	FI66385C (sv)
FR (1)	FR2441627A1 (sv)
GB (1)	GB2038315B (sv)
IE (1)	IE49116B1 (sv)
IL (1)	IL58730A (sv)
IT (1)	IT1127231B (sv)
LU (1)	LU81890A1 (sv)
NL (1)	NL177689C (sv)
PH (1)	PH15672A (sv)
PT (1)	PT70452A (sv)
SE (1)	SE447731B (sv)
YU (1)	YU41678B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU532110B2 (en) *	1979-11-13	1983-09-15	Ici Ltd.	Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
EP0065393B1 (en) *	1981-05-12	1984-12-27	Imperial Chemical Industries Plc	Pyrrole derivatives
US4540700A (en) *	1982-04-15	1985-09-10	Alcon Laboratories, Inc.	Treatment of diabetic complications with certain spiro-imidazolidine-diones
JPS59500618A (ja) *	1982-04-15	1984-04-12	アルコン・ラボラトリ−ズ・インコ−ポレ−テッド	スピロ―フルオロフルオレン化合物、その製造法およびアルド―スレダクターゼ活性を阻害する組成物
US4438272A (en)	1982-04-15	1984-03-20	Alcon Laboratories, Inc.	Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4436745A (en)	1982-04-15	1984-03-13	Alcon Laboratories, Inc.	Method of inhibiting aldose reductase activity
US4464385A (en) *	1982-04-15	1984-08-07	Alcon Laboratories, Inc.	Treatment of diabetic complications with hydantoins
IL68314A0 (en) *	1982-04-15	1983-07-31	Alcon Lab Inc	Method and composition for inhibiting aldose reductase activity and process for preparing spirofluorofluoren and spiro-difluorofluoren compounds
DE3342933A1 (de) *	1983-11-26	1985-06-05	Horst G. 5190 Stolberg Schumann	Regalfoerderzeug
US4600717A (en) *	1984-04-11	1986-07-15	Alcon Laboratories, Inc.	Aldose reductase inhibitors useful in ophthalmic wound healing
US4717725A (en) *	1984-04-11	1988-01-05	Alcon Laboratories, Inc.	Ophthalmic wound healing with aldose reductase inhibitors
US4609663A (en) *	1984-09-11	1986-09-02	Alcon Laboratories, Inc.	Aldose reductase inhibitors useful in glaucoma therapy
US4576143A (en) *	1984-10-05	1986-03-18	Clark Iii William T	Method of immune modification by means of extracorporeal irradiation of the blood
US4966911A (en) *	1984-11-20	1990-10-30	Washington Research Foundation	Immunoregulatory agents
US5340829A (en) *	1984-11-20	1994-08-23	Washington Research Foundation	Immunoregulatory agents
JPS6372140U (sv) *	1986-10-29	1988-05-14
JPS63119451U (sv) *	1987-01-30	1988-08-02
JPH05508386A (ja) *	1989-02-10	1993-11-25	ワシントン　リサーチ　ファンデション	免疫調整剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2683718A (en) *	1952-01-11	1954-07-13	Searle & Co	Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione
DE1032257B (de) *	1954-05-27	1958-06-19	Cutter Lab	Verfahren zur Herstellung neuer Hydantoine
GB796069A (en) *	1955-12-23	1958-06-04	Ici Ltd	Substituted hydantoins
GB818724A (en) *	1956-10-18	1959-08-19	Ici Ltd	Hydantoin derivatives
US3532744A (en) *	1967-07-28	1970-10-06	American Home Prod	1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) *	1972-07-10	1974-06-28	Ayerst Mckenna & Harrison	Compositions for and a method of treating diabetic complications
US4078064A (en) *	1976-08-18	1978-03-07	E. R. Squibb & Sons, Inc.	8H-Pyrazolo[4',3':5,6]pyrido[3,4-e][1,2,4]triazolo[1,5-a]pyrimidines
US4117230A (en) *	1976-10-18	1978-09-26	Pfizer Inc.	Hydantoin derivatives as therapeutic agents
CA1088945A (en) *	1976-10-18	1980-11-04	Pfizer Limited	Hydantoin derivatives as therapeutic agents
US4130714A (en) *	1977-05-23	1978-12-19	Pfizer Inc.	Hydantoin therapeutic agents
US4127665A (en) *	1978-01-18	1978-11-28	Pfizer Inc.	Thienohydantoin derivatives

1978
- 1978-11-16 US US05/961,335 patent/US4181728A/en not_active Expired - Lifetime
1979
- 1979-11-12 YU YU2773/79A patent/YU41678B/xx unknown
- 1979-11-13 GB GB7939211A patent/GB2038315B/en not_active Expired
- 1979-11-14 PT PT70452A patent/PT70452A/pt unknown
- 1979-11-14 PH PH23277A patent/PH15672A/en unknown
- 1979-11-14 JP JP54147592A patent/JPS6052157B2/ja not_active Expired
- 1979-11-14 DE DE19792946037 patent/DE2946037A1/de not_active Ceased
- 1979-11-14 IE IE2184/79A patent/IE49116B1/en not_active IP Right Cessation
- 1979-11-15 AR AR278904A patent/AR222052A1/es active
- 1979-11-15 ES ES486007A patent/ES486007A1/es not_active Expired
- 1979-11-15 CH CH1021479A patent/CH642358A5/fr not_active IP Right Cessation
- 1979-11-15 NL NLAANVRAGE7908352,A patent/NL177689C/xx not_active IP Right Cessation
- 1979-11-15 IT IT27311/79A patent/IT1127231B/it active
- 1979-11-15 DK DK484479A patent/DK484479A/da not_active Application Discontinuation
- 1979-11-15 SE SE7909439A patent/SE447731B/sv not_active IP Right Cessation
- 1979-11-15 LU LU81890A patent/LU81890A1/fr unknown
- 1979-11-15 AU AU52880/79A patent/AU515301B2/en not_active Ceased
- 1979-11-15 AT AT0729779A patent/AT369742B/de not_active IP Right Cessation
- 1979-11-15 IL IL58730A patent/IL58730A/xx not_active IP Right Cessation
- 1979-11-15 FR FR7928234A patent/FR2441627A1/fr active Granted
- 1979-11-15 FI FI793586A patent/FI66385C/fi not_active IP Right Cessation
- 1979-11-16 CA CA340,068A patent/CA1125294A/en not_active Expired
- 1979-11-16 BE BE0/198129A patent/BE880065A/fr not_active IP Right Cessation
1984
- 1984-10-23 JP JP59222857A patent/JPS60120870A/ja active Granted

Also Published As

Publication number	Publication date
NL7908352A (nl)	1980-05-20
FI66385B (fi)	1984-06-29
YU277379A (en)	1983-01-21
IE792184L (en)	1980-05-16
DE2946037A1 (de)	1980-05-22
DK484479A (da)	1980-05-17
AT369742B (de)	1983-01-25
NL177689B (nl)	1985-06-03
CH642358A5 (fr)	1984-04-13
PH15672A (en)	1983-03-11
SE447731B (sv)	1986-12-08
FR2441627B1 (sv)	1983-06-03
NL177689C (nl)	1985-11-01
IT1127231B (it)	1986-05-21
IE49116B1 (en)	1985-08-07
FR2441627A1 (fr)	1980-06-13
ATA729779A (de)	1982-06-15
IL58730A0 (en)	1980-02-29
AR222052A1 (es)	1981-04-15
BE880065A (fr)	1980-05-16
AU5288079A (en)	1980-05-22
IL58730A (en)	1984-01-31
JPS5589268A (en)	1980-07-05
JPS60120870A (ja)	1985-06-28
YU41678B (en)	1987-12-31
IT7927311A0 (it)	1979-11-15
ES486007A1 (es)	1980-09-01
GB2038315B (en)	1982-08-11
FI793586A7 (fi)	1980-05-17
CA1125294A (en)	1982-06-08
JPS6052157B2 (ja)	1985-11-18
GB2038315A (en)	1980-07-23
JPS6144868B2 (sv)	1986-10-04
LU81890A1 (fr)	1980-06-05
US4181728A (en)	1980-01-01
FI66385C (fi)	1984-10-10
AU515301B2 (en)	1981-03-26
PT70452A (en)	1979-12-01

Legal Events

Date

Code

Title

Description

1995-01-31

NAL

Patent in force

Ref document number: 7909439-7

Format of ref document f/p: F

1995-08-07

NUG

Patent has lapsed